DIBIASE MARY (Chief Operating Officer) sold 0.3% of their position (464.00 shares) of X4 PHARMACEUTICALS, INC on the open market
Open‑market sale worth $876.96 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/5/2023ACC: 0001628280-23-024229
Officer· Chief Operating Officer
Since Sep 2021
-464.00
Net shares
Net seller
$876.96
Total sold
1
Open market trades
0B · 1S
1
Total transactions
464.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−464.00
Price / share
$1.89
Trade value
$876.96
% of position
0.3%
6/30/2023
151K→150.54K
Total
Net shares
−464.00
Net value
-$876.96
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2023 | S · Sale | −464.00 | $1.89 | $876.96 | 0.3% | 151K | 150.54K |
| Total | −464.00 | -$876.96 | ||||||
Derivative Transactions0
No derivative transactions reported